Menu
GWAS Study

Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis.

Kottyan LC, Maddox A, Braxton JR et al.

29904099 PubMed ID
GWAS Study Type
4944 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KL
Kottyan LC
MA
Maddox A
BJ
Braxton JR
SE
Stucke EM
MV
Mukkada V
PP
Putnam PE
AJ
Abonia JP
CM
Chehade M
WR
Wood RA
PR
Pesek RD
VB
Vickery BP
FG
Furuta GT
DP
Dawson P
SH
Sampson HA
ML
Martin LJ
KJ
Kelly JA
KR
Kimberly RP
SK
Sivils K
GP
Gaffney PM
KK
Kaufman K
HJ
Harley JB
RM
Rothenberg ME
Chapter II

Abstract

Summary of the research findings

Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus triggered by immune hypersensitivity to food. Herein, we tested whether genetic risk factors for known, non-allergic, immune-mediated diseases, particularly those involving autoimmunity, were associated with EoE risk. We used the high-density Immunochip platform, encoding 200,000 genetic variants for major auto-immune disease. Accordingly, 1214 subjects with EoE of European ancestry and 3734 population controls were genotyped and assessed using data directly generated or imputed from the previously published GWAS. We found lack of association of EoE with the genetic variants in the major histocompatibility complex (MHC) class I, II, and III genes and nearly all other loci using a highly powered study design with dense genotyping throughout the locus. Importantly, we identified an EoE risk locus at 16p13 with genome-wide significance (Pcombined=2.05 × 10-9, odds ratio = 0.76-0.81). This region is known to encode for the genes CLEC16A, DEXI, and CIITI, which are expressed in immune cells and esophageal epithelial cells. Suggestive EoE risk were also seen 5q23 (intergenic) and 7p15 (JAZF1). Overall, we have identified an additional EoE risk locus at 16p13 and highlight a shared and unique genetic etiology of EoE with a spectrum of immune-associated diseases.

1,210 European ancestry cases, 3,734 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

4944
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.